Preventive medicineHumansBuprenorphineOpioid-Related DisordersPractice PatternsPhysicians'
Training in medications for opioid use disorder and buprenorphine prescribing in the post X-waiver era: Insights from a nationwide, multispecialty survey.
Sung In H Kim-Vences, Justin Nguyen, Jacqueline M Hirth, Kyle P Suen, Colleen A Keough, Roger Zoorob, Alicia A Kowalchuk
Published: 202610.1016/j.ypmed.2025.108485
Abstract
OBJECTIVE: The January 2023 repeal of the X-waiver aimed to reduce regulatory barriers to buprenorphine prescribing and enhance patient access to medications for opioid use disorder (MOUD). Its impact on prescribing by non-addiction-trained physician…
Preview only. Read the full abstract at the source